Qube Research & Technologies LTD Mereo Biopharma Group PLC Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 49,687 shares of MREO stock, worth $174,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,687
Previous 33,287
49.27%
Holding current value
$174,898
Previous $119,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MREO
# of Institutions
84Shares Held
107MCall Options Held
209KPut Options Held
479K-
Rubric Capital Management LP New York, NY15.3MShares$53.9 Million1.75% of portfolio
-
Janus Henderson Group PLC London, X012.3MShares$43.5 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.72MShares$34.2 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.53MShares$33.6 Million1.33% of portfolio
-
Mangrove Partners New York, NY8.73MShares$30.7 Million4.66% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $440M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...